Abstract
COLONY STIMULATING FACTORS (CSFs) stimulate isolated haemopoietic progenitor cells to differentiate and form granulocyte and/or macrophage colonies in vitro1,2. There seem to be at least two distinct subclasses of CSF, those stimulating macrophage colony formation and those stimulating granulocytic colony formation. Purified CSF from mouse L cell-conditioned medium is a 70,000 molecular weight glycoprotein, comprising two disulphide-bonded 35,000 MW subunits3. At concentrations as low as 10−12 M it stimulates macrophage colony formation by murine bone marrow cells. It has similar physicochemical properties to, and shared antigenic determinants with, the CSF from human urine3–6. This type of CSF has been shown6 to share identity with the macrophage growth factor of Virolainen and Defendi7 that stimulates proliferation of peritoneal exudate macrophages. The purified CSF was also active6 in stimulating macrophage colony formation by peritoneal exudate cells in the agar culture system of Lin and Stewart8. We now report that this same kind of CSF is the molecule responsible for the proliferation of mononuclear phagocytes from several haemopoietic and nonhaemopoietic tissues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pluznik, D. H. & Sachs, L. J. cell. Physiol. 66, 319–324 (1965).
Bradley, T. R. & Metcalf, D. Aust. J. exp. Biol. med. Sci. 44, 287–299 (1966).
Stanley, E. R. & Heard, P. M. J. biol. Chem. 252, 4305–4312 (1977).
Stanley, E. R. & Metcalf, D. Aust. J. exp. Biol. med. Sci. 47, 467–483 (1969).
Stanley, E. R., Hansen, G., Woodcock, J. & Metcalf, D. Fedn Proc. 34, 2272–2278 (1975).
Stanley, E. R., Cifone, M., Heard, P. M. & Defendi, V. J. exp. Med. 143, 631–647 (1976).
Virolainen, M. & Defendi, V. Wistar Inst. Symp. Monogr. 7, 67–85 (1967).
Lin, H.-S. & Stewart, C. C. J. cell. Physiol. 83, 369–378 (1974).
Worton, R. G., McCulloch, E. A. & Till, J. E. J. cell. Physiol. 74, 171–182 (1969).
Till, J. E., Whitmore, G. F. & Gulyas, S. Biochim. biophys. Acta 72, 277–289 (1963).
Stanley, E. R., Metcalf, D., Maritz, J. S. & Yeo, G. F. J. Lab. clin. Med. 79, 657–668 (1972).
Metcalf, D. J. cell. Physiol. 76, 89–99 (1970).
Lin, H.-S., Kuhn, C. & Kuo, T. T. J. exp. Med. 142, 877–886 (1975).
Lin, H.-S. Blood 49, 593–598 (1977).
Berg, T. & Boman, D. Biochim. biophys. Acta 321, 585–596 (1973).
Chen, D.-M., Lin, H.-S., Stahl, P. & Stanley, E. R. (in preparation).
Soderland, S. C. & Naum, Y. Nature 245, 150–152 (1973).
Naum, Y. Cytobios 14, 211–220 (1975).
Bennett, B. J. exp. Med. 48, 165–181 (1966).
Adolphe, M., Fontagne, J., Pelletier, M. & Giroud, J. P. Nature 253, 637 (1975).
Wynne, K. M., Spector, W. G. & Willoughby, D. A. Nature 253, 636–637 (1957).
Bradley, T. R., Metcalf, D., Sumner, M. & Stanley, R. In Vitro 4, 22–35 (1969).
Chu, J. & Lin, H.-S. J. reticuloendothel. Soc. 20, 299–305 (1976).
Mac Vittie, T. J. & McCarthy, K. F. J. cell. Physiol. 92, 203–208 (1977).
Stanley, E. R. J. Supramolec. Struct. Suppl. 2, 175 (1978).
Guilbert, L. J. & Iscove, N. N. Nature 263, 594–595 (1976).
VanFurth, R. et al. Bull. W.H.O. 46, 845–852 (1972).
Aschoff, L. Ergebn. Inn. Med. Kunderheilk. 26, 1–118 (1924).
Kurland, J. & Moore, M. A. S. Expl Hemat. 5, 357–373 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
STANLEY, E., CHEN, DM. & LIN, HS. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 274, 168–170 (1978). https://doi.org/10.1038/274168a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/274168a0
This article is cited by
-
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Journal of Cancer Research and Clinical Oncology (2023)
-
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Experimental Hematology & Oncology (2021)
-
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer
Journal of Hematology & Oncology (2020)
-
Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors
Investigational New Drugs (2020)
-
An Efficient and Rapid Two-step Purification Method for Active Human Macrophage Colony-stimulating Factor from Escherichia coli
Biotechnology and Bioprocess Engineering (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.